Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
45.91
-1.21 (-2.57%)
Mar 3, 2026, 4:00 PM EST - Market closed
GNOM Holdings Information
GNOM is an equity ETF with a total of 51 individual holdings. The top holdings are Moderna stock at 7.86%, Praxis Precision Medicines at 6.23%, Arrowhead Pharmaceuticals at 5.69%, Illumina at 5.13%, and Guardant Health at 4.71%.
Total Holdings
51
Top 10 Percentage
49.77%
Asset Class
Equity
ETF Category
Health
Assets
51.54M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 7.86% |
| 2 | PRAX | Praxis Precision Medicines, Inc. | 6.23% |
| 3 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.69% |
| 4 | ILMN | Illumina, Inc. | 5.13% |
| 5 | GH | Guardant Health, Inc. | 4.71% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.32% |
| 7 | BMRN | BioMarin Pharmaceutical Inc. | 4.31% |
| 8 | NTRA | Natera, Inc. | 3.91% |
| 9 | BNTX | BioNTech SE | 3.87% |
| 10 | RNAGBP | Avidity Biosciences Inc Ordinary Shares | 3.75% |
| 11 | QGEN | Qiagen N.V. | 3.63% |
| 12 | CRSP | CRISPR Therapeutics AG | 3.48% |
| 13 | TECH | Bio-Techne Corporation | 3.45% |
| 14 | BMY | Bristol-Myers Squibb Company | 2.65% |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.50% |
| 16 | VCYT | Veracyte, Inc. | 2.39% |
| 17 | LLY | Eli Lilly and Company | 2.34% |
| 18 | TWST | Twist Bioscience Corporation | 2.30% |
| 19 | GILD | Gilead Sciences, Inc. | 2.28% |
| 20 | LON: AZN | AstraZeneca PLC | 2.28% |
| 21 | BEAM | Beam Therapeutics Inc. | 2.21% |
| 22 | TXG | 10x Genomics, Inc. | 2.16% |
| 23 | LEGN | Legend Biotech Corporation | 2.14% |
| 24 | RARE | Ultragenyx Pharmaceutical Inc. | 1.78% |
| 25 | WGS | GeneDx Holdings Corp. | 1.72% |
As of Feb 27, 2026